I didn’t catch todays webinar, but last week he said they can do two things, 1 is rush this and get it into the clinic as soon as possible or 2, take the time to optimise the trial.
I think it would be fair to assume that they are going to delay the trial so they can take advantage of the use of Thermofishers technology, just another cap in the feather for Omnicar to further stand out from the pack. Clinical trials take a long time, what’s the harm in a couple of months to further strengthen the IP.
He also said he is going to provide an update on Omnicar soon, which I am expecting to be in next mondays webinar.
PTX Price at posting:
9.2¢ Sentiment: Buy Disclosure: Held
